Rapid Screens Can Predict COVID-19 Infection with Nearly Same Precision as Antibody Tests Conducted in Labs
New findings from a Michigan Medicine study reveal that antibody testing is predictive of prior COVID-19 infection, and rapid screening methods – even from finger pricks – are effective testing tools. More...02 Apr 2021
New Technology Halves Time Currently Taken to Identify If Positive COVID-19 Sample Contains Variant of Concern
A groundbreaking new technology to rapidly detect new COVID mutations indicating whether positive test samples contain known variants is being trialed by the UK government. More...01 Apr 2021
Bioneer Launches World's First Precision Auxiliary Device for Sample Loading
Bioneer Corporation (Daejeon, Korea) has launched a new concept auxiliary device, AccuLoader, designed to assist with the dispensation of samples and reagents to the correct wells and reduce the time spent on the sample preparation. More...01 Apr 2021
COVID-19 Test Uses Novel High-Throughput Molecular Method for Detecting SARS-CoV-2 Infection in Saliva Samples
A new COVID-19 test uses a high-throughput molecular method for detecting infection by SARS-CoV-2 in specimens of saliva from individuals, allowing for fast and accurate detection of infection by the virus. More...30 Mar 2021
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
Newborn Screening Test
NeoMass AAAC 3.0
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test
In Other News
COVID-19 Group Testing Method Delivers Results 13 Times Faster than Individual Testing of Each Sample
Novel 15-Minute Microfluidic DLD Assay Could Assess Severity of Immune Response to COVID-19 Infection
New Mass Spectrometry-Based Technique Enables Ultrafast Identification of COVID-19 Biomarkers
Evidence of SARS-CoV-2 Infecting Mouth’s Cells Further Confirms Reliability of Saliva Testing for Diagnosing COVID-19
AACC Issues Updated Recommendations on Uses and Limitations of COVID-19 Antibody Tests
Rapid Antigen Tests Better at Correctly Identifying COVID-19 in People with Symptoms than in People Without Symptoms
Beckman Coulter's SARS-CoV-2 IgG II Antibody Test Receives FDA Emergency Use Authorization
First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay Receives FDA EUA
Carolina Liquid Chemistries Offers FDA Emergency Use Authorized POC COVID-19/Flu A&B Combo Test
Highly Accurate Prognostic Test Predicts Personalized Risk of Severe Illness Due to SARS-CoV-2 Virus
Ortho's VITROS SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA EUA for New Performance, Sensitivity Data
Thermo Fisher Collaborates with Artificial to Accelerate COVID-19 Diagnostics
Eurofins Launches Upgraded RT-PCR Kit for Identification of Mutations Associated with SARS-CoV-2 Variants of Concern
Low Cost Pinprick COVID-19 Test Detects SARS-CoV-2 Antibodies in Drop of Blood in Under an Hour
New Ultra-Absorptive Nanofiber Swabs Could Improve COVID-19 Test Sensitivity
Automated System for SARS-CoV-2 Analysis in Wastewater to Enable Early Detection of COVID-19 Prevalence and Mutants
BioMérieux BIOFIRE Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 Becomes First COVID-19 Diagnostic Test to Obtain De Novo FDA Authorization
Direct, Cost-Effective COVID-19 Tests Identify UK/South African SARS-CoV-2 Variant and Reduces Test Time from Days to Hours
Rapid Saliva-Based Test for COVID-19 Antibodies Could Scale Up Testing to Track Spread of SARS-CoV-2
Roche Launches New SARS-CoV-2 Variant Test to Monitor Emerging Coronavirus Mutations
Snibe Diagnostic SARS-CoV-2 Antigen Assay Secures CE Mark
New Saliva-Based COVID-19 Test is Less Invasive, More Accessible and Delivers Accurate Results at Lower Cost
Non-Invasive Skin Swab Samples Enough to Quickly Detect COVID-19, Finds New Study
